A cell function study on calcium regulation of a novel calcium-sensing receptor mutation (p.Tyr825Phe)
1
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Purpose: Autosomal dominant hypocalcemia with hypercalciuria is a genetic disease characterized by hypoparathyroidism with hypercalciuria. We discovered a novel variant (p.Tyr825Phe[Y825F]) of the CASR gene in a neonate with congenital hypoparathyroidism and hypercalciuria and conducted a cell function study to determine whether the CASR-Y825F variant was pathogenic. Methods: To perform a functional study on CaSR-Y825F, we constructed expression vectors expressing wild-type (WT) CASR and CASR-Y825F. After transfection of each expression vector into HEK293 cells, we examined alterations in intracellular signaling. Mitogen-activated protein kinase (MAPK) signaling activity of HEK293 cells expressing CASR-WT or CASR-Y825F was determined. Changes in intracellular calcium ions ([Ca2+]i) by extracellular calcium ion ([Ca2+]e) stimulation were quantitatively compared and analyzed. Results: Cells expressing CASR-Y825F showed elevated of MAPK signaling (phospho-ERK [pERK], phospho-JNK [pJNK], phospho-p38 [pp38]) and increased [Ca2+]i levels at low [Ca2+]e stimulation compared with cells expressing CASR-WT. Additionally, [Ca2+]i levels in HEK293 cells expression CASR-WT and CASR-Y825F were determined at 340 nm/380 nm wavelength ratios using Fura-2 AM. At [Ca2+]e concentrations of 2.5 mM and 3 mM, the ratios of CASR-Y825F cells were higher (2.6 and 3.5, respectively) than those of CASR-WT cells (1.04 and 1.40, respectively). Conclusion: This cell function study proved that the CASR-Y825F expressed in HEK293 cells elevated MAPK signaling (pERK, pJNK, pp38) and increased [Ca2+]i to induce hypocalcemia.
Abstract
Purpose: Autosomal dominant hypocalcemia with hypercalciuria is a genetic disease characterized by hypoparathyroidism with hypercalciuria. We discovered a novel variant (p.Tyr825Phe[Y825F]) of the CASR gene in a neonate with congenital hypoparathyroidism and hypercalciuria and conducted a cell function study to determine whether the CASR-Y825F variant was pathogenic. Methods: To perform a functional study on CaSR-Y825F, we constructed expression vectors expressing wild-type (WT) CASR and CASR-Y825F. After transfection of each expression vector into HEK293 cells, we examined alterations in intracellular signaling. Mitogen-activated protein kinase (MAPK) signaling activity of HEK293 cells expressing CASR-WT or CASR-Y825F was determined. Changes in intracellular calcium ions ([Ca2+]i) by extracellular calcium ion ([Ca2+]e) stimulation were quantitatively compared and analyzed. Results: Cells expressing CASR-Y825F showed elevated of MAPK signaling (phospho-ERK [pERK], phospho-JNK [pJNK], phospho-p38 [pp38]) and increased [Ca2+]i levels at low [Ca2+]e stimulation compared with cells expressing CASR-WT. Additionally, [Ca2+]i levels in HEK293 cells expression CASR-WT and CASR-Y825F were determined at 340 nm/380 nm wavelength ratios using Fura-2 AM. At [Ca2+]e concentrations of 2.5 mM and 3 mM, the ratios of CASR-Y825F cells were higher (2.6 and 3.5, respectively) than those of CASR-WT cells (1.04 and 1.40, respectively). Conclusion: This cell function study proved that the CASR-Y825F expressed in HEK293 cells elevated MAPK signaling (pERK, pJNK, pp38) and increased [Ca2+]i to induce hypocalcemia.
참고문헌 (28)
- Pollak MR, "Autosomal dominant hypocalcaemia caused by a Ca2+-sensing receptor gene mutation", Nat Genet, 83, pp.303~307 (1994)
- D'Souza-Li L, "Identification and functional characterization of novel calcium-sensing receptor mutations in familial hypocalciuric hypercalcemia and autosomal dominant hypocalcemia", J Clin Endocrinol Metab, 87, pp.1309~1318 (2002)
- Janicic N, "Mapping of the calcium-sensing receptor gene(CASR)to human chromosome 3q13. 3-21 by fluorescence in situ hybridization, and localization to rat chromosome 11 and mouse chromosome 16", Mamm Genome, 6, pp.798~801 (1995)
- 최근희, "Autosomal dominant hypocalcemia with Bartter syndrome due to a novel activating mutation of calcium sensing receptor, Y829C", Clinical and Experimental Pediatrics, 58(4), pp.148~153 (2015), 대한소아청소년과학회
- Jianxin Hu, "Spiegel. Structure and function of the human calcium-sensing receptor : insights from natural and engineered mutations and allosteric modulators", J Cell Mol Med, 11, pp.908~922 (2007)
- Hendy GN, "Mutations of the calcium-sensing receptor(CASR)in familial hypocalciuric hypercalcemia, neonatal severe hyperparathyroidism, and autosomal dominant hypocalcemia", Hum Mutat, 16, pp.281~296 (2000)
- Hofer AM, "Calcium : extracellular calcium sensing and signalling", Nat Rev Mol Cell Biol, 4, pp.530~538 (2003)
- Brown EM, "Clinical lessons from the calcium-sensing receptor", Nat Rev Endocrinol, 3, pp.122~ (2007)
- Hannan FM, "Identification of 70 calcium-sensing receptor mutations in hyper-and hypo-calcaemic patients : evidence for clustering of extracellular domain mutations at calcium-binding sites", Hum Mol Genet, 21, pp.2768~2778 (2012)
- "Medical Genetics and Human Variation"[URL]
- Thakker RV, "Diseases associated with the extracellular calcium-sensing receptor", Cell calcium, 35, pp.275~282 (2004)
- 문정은, "De novo a novel variant of CaSR gene in a neonate with congenital hypoparathyroidism", Annals of Pediatric Endocrinology & Metabolism, 23(2), pp.107~111 (2018), 대한소아내분비학회
- Baran N, "Novel activating mutation of human calcium-sensing receptor in a family with autosomal dominant hypocalcaemia", Mol Cell Endocrinol, 407, pp.18~25 (2015)
- Arora NK, "Morbidity and mortality in term infants with intrauterine growth retardation", J Trop Pediatr, 33, pp.186~189 (1987)
- Tsang RC, "Neonatal hypocalcemia in infants with birth asphyxia", J Pediatr, 84, pp.428~433 (1974)
- Arthur JM, "The calcium-sensing receptor stimulates JNK in MDCK cells", Biochem Biophys Res Commun, 275, pp.538~541 (2000)
- Brown EM, "Calcium sensing by endocrine cells", Endocr Pathol, 153, pp.187~219 (2004)
- Huang C, "The calcium-sensing receptor and its interacting proteins", J Cell Mol Med, 11, pp.923~934 (2007)
- Chattopadhyay N, "Mitogenic action of calcium-sensing receptor on rat calvarial osteoblasts", Endocrinology, 145, pp.3451~3462 (2004)
- Pearce SH, "A familial syndrome of hypocalcemia with hypercalciuria due to mutations in the calcium-sensing receptor", N Engl J Med, 335, pp.1115~1122 (1996)
- Bräuner-Osborne H, "The agonist-binding domain of the calcium-sensing receptor is located at the amino-terminal domain", J Biol Chem, 274, pp.18382~18386 (1999)
- Holstein DM, "Calcium-sensing receptor-mediated ERK1", 2 activation requires Gαi2 coupling and dynaminindependent receptor internalization, 2004, pp.279, 10060~10069
- Kifor O, "Regulation of MAP kinase by calcium-sensing receptor in bovine parathyroid and CaR-transfected HEK293 cells", Am J Physiol Renal Physiol, 280, pp.F291~F302 (2001)
- Handlogten ME, "Extracellular Ca2+-sensing receptor is a promiscuous divalent cation sensor that responds to lead", Am J Physiol Renal Physiol, 279, pp.F1083~F1091 (2000)
- Handlogten ME, "The Ca2+-sensing receptor activates cytosolic phospholipase A2 via a Gqα-dependent ERK-independent pathway", J Biol Chem, 276, pp.13941~13948 (2001)
- Bai M, "Expression and characterization of inactivating and activating mutations in the human Ca2+(o)-sensing receptor", J Biol Chem, 271, pp.19537~19545 (1996)
- Leach K, "Identification of molecular phenotypes and biased signaling induced by naturally occurring mutations of the human calcium-sensing receptor", Endocrinology, 159, pp.4304~4316 (2012)
- Zhao XM, "A missense mutation in the seventh transmembrane domain constitutively activates the human Ca2+receptor", FEBS Lett, 448, pp.180~184 (1999)